Literature DB >> 8891848

Cirrhosis negatively affects the efficiency of serologic diagnosis of Helicobacter pylori infection.

G Nardone1, P Coscione, F P D'Armiento, M Del Pezzo, M Pontillo, G Mossetti, C Lamberti, G Budillon.   

Abstract

In cirrhosis, Helicobacter pylori infection may be implicated, together with portal hypertension, bile reflux and alcohol abuse, in damage to gastric mucosa. Aim of this study was to define the influence of non-alcoholic liver disease on the incidence of Helicobacter pylori infection and on the diagnostic accuracy of specific serology. Enrolled in the study were 232 individuals, 105 also had cirrhosis. Infection by Helicobacter pylori, diagnosed by a positive concordance of quick urease test and histology, was detected in 97 (48 with cirrhosis) out of 184 patients. Severe gastritis was more frequent in patients with Helicobacter pylori infection than in patients without. Cirrhosis did not significantly affect the prevalence of Helicobacter pylori infection or the histological features of gastritis. Specific anti-Helicobacter pylori IgG and IgA assay (Bio-Rad GAP test) was used for serological diagnosis. Anti-Helicobacter pylori IgG showed a high sensitivity (85% in cirrhotics, 89% in non-cirrhotics) and low specificity being more evident in cirrhotics (38% vs 56% non-cirrhotics). Serum specific IgA showed low sensitivity (approximately 25% in both groups) and specificity of 79% in cirrhotics vs 84% in non-cirrhotics. In conclusion, non-alcoholic cirrhosis does not affect the incidence of Helicobacter pylori infection and the histological features of chronic gastritis but does decrease diagnostic efficiency of serological tests for Helicobacter pylori.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891848

Source DB:  PubMed          Journal:  Ital J Gastroenterol        ISSN: 0392-0623


  6 in total

Review 1.  Evaluation of commercially available Helicobacter pylori serology kits: a review.

Authors:  R J Laheij; H Straatman; J B Jansen; A L Verbeek
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

2.  Immune responses to bile-tolerant helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors.

Authors:  Olga Ananieva; Ingrid Nilsson; Tamara Vorobjova; Raivo Uibo; Torkel Wadström
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis.

Authors:  Gabriele I Kirchner; Winfried Beil; Joerg S Bleck; Micheal P Manns; Siegfried Wagner
Journal:  Int J Clin Exp Med       Date:  2010-12-25

Review 4.  Blood tests in the management of Helicobacter pylori infection. Italian Helicobacter pylori Study Group.

Authors:  D Vaira; J Holton; M Menegatti; F Landi; C Ricci; A Ali; L Gatta; S Farinelli; C Acciardi; B Massardi; M Miglioli
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

5.  Helicobacter pylori and portal hypertensive gastropathy: any new information?

Authors:  Angelo Zullo; Cesare Hassan; Lorenzo Ridola; Vincenzo De Francesco
Journal:  Ann Gastroenterol       Date:  2014

6.  Association of Helicobacter pylori with elevated blood ammonia levels in cirrhotic patients: a meta-analysis.

Authors:  Hai-Xing Jiang; Shan-Yu Qin; Zhi-gang Min; Ming-Zhi Xie; Tao Lin; Bang-Li Hu; Xiao-Yun Guo
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.